1 Patient enrollment flow chart.

Slides:

Advertisements

Similar presentations

Inflammatory Bowel Disease: Overview

Advertisements

Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald.

25 January 2013 Dr Ian Arnott UK Inflammatory Bowel Disease (IBD) audit Audit of inpatients with ulcerative colitis 1st January 2013 – 31st December 2013.

Do We Need to Screen our IBD Patients for Depression: The Prevalence and Severity of Depression within a Typical DGH Cohort of IBD Patients N. Swart 1,

Date of presentation Name of presenter UK IBD Audit 3 rd Round Comparison of (Your Site Name) results against the National Results for Clinical Audit of.

The Use of a Faecal Calprotectin Service in Routine Practice Can Help in Clinical Dilemma and Significantly Reduce Unnecessary Colonoscopy. M. W. Johnson,

TABLE OF CONTENTS CHAPTER 3.0: Utilization and Volume Chart 3.1: Inpatient Admissions in Community Hospitals, 1990 – 2010 Chart 3.2: Total Inpatient Days.

Coastal Hillside Family Medicine.  “All team based care models require some level of change in the roles and responsibilities of individual professionals,

Baumgart, D C The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis Dtsch Arztebl Int 2009; 106(8): ; DOI: /arztebl

CHAPTER 19 Inflammatory Bowel Disease Source: Burden of digestive diseases in the United States, NIH Publication No

IBD SSHAMP Dr. Matt W. Johnson Inflammatory Bowel Disease Supported, Self Help And Management Programme.

Xavier Roblin, MD, PhD 1, M. Rinaudo, MD 2, E. Del Tedesco, MD 1, J.M. Phelip, MD, PhD 1, C. Genin, MD, PhD 2, L. Peyrin-Biroulet, MD, PhD 3 and S. Paul,

Page  2 Accutane, a medication used to treat acne, has recently been linked to dangerous health conditions such as inflammatory bowel disease (IBD).

Chart 3.1: Inpatient Admissions in Community Hospitals, 1993 – 2013 Source: Avalere Health analysis of American Hospital Association Annual Survey data,

Pre - Post ACA Hospital Utilization Experience

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

Inflammatory Bowel Disease (IBD) is a Risk Factor for Extrahepatic Cholangiocarcinoma (ECC) in Subjects Without Underlying Primary Sclerosing Cholangitis.

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

CTC Clinical Strategy and Cost Committee

Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

YouTube® and inflammatory bowel disease

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Utilization and Volume

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Clinical Nutrition University: Nutrition in the prevention and management of irritable bowel syndrome, constipation and diverticulosis Eduard Cabré

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Medical management of inflammatory bowel disease

Health Care and Research

Figure 1 (A): The 0-Isp polyp mimicking inflammatory polyp was found at hepatic flexure. The top surface of the polyp was depressed. (B): Hematoxylin stain.

Figure ES-1. Health Status and Employment

Serum prohepcidin levels in chronic inflammatory bowel diseases

Endothelial function and cardiovascular risk in active inflammatory bowel diseases Mariabeatrice Principi, Mario Mastrolonardo, Pietro Scicchitano, Michele.

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla.

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Get Here is the best Treatment for Ulcerative Colitis

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

CHAPTER 3 Utilization and Volume.

Managing IBD in Children

Volume 147, Issue 4, Pages e7 (October 2014)

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Total adult population

Research and Healthcare in Inflammatory Bowel Diseases (1)

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Osteoporosis in inflammatory bowel disease

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Volume 131, Issue 3, Pages (September 2006)

New Tool to Help Prevent Readmissions Modified LACE Tool

Subrata Ghosh, Benjamin Pariente, Diane R

Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis S.D. McLaughlin, A. Culkin,

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

National differences in ulcerative colitis experience and management among patients from five European countries and Canada: An online survey Stefan.

Individual patients’ FCP (μg/g) values (n=119).

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Rounds® Patient Experience Clinic Program

Eligibility criteria for inclusion as an expert Delphi panellist

Total Outpatient Visits

Emergency Departments(1)

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Seasonal variation in flares of inflammatory bowel disease

Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.

Approach to 25(OH)D supplementation in patients with IBD

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis Tine Jess, Anthony Lopez, Mikael Andersson,

Presentation transcript:

1 Patient enrollment flow chart. From: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study☆ J Crohns Colitis. 2014;8(7):598-606. doi:10.1016/j.crohns.2013.11.017 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation

2 A) Percentage of patients with each frequency of visits to health care providers for UC-related health care in the past 12 months. Data collected from patient survey (N = 175). B) Percentage of patients who reported each frequency of visits to health care providers for UC-related health care in the past 3 months. Data collected from chart review (N = 175). IBD, inflammatory bowel disease; UC, ulcerative colitis. From: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study☆ J Crohns Colitis. 2014;8(7):598-606. doi:10.1016/j.crohns.2013.11.017 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation

3 Percentage of patients with each frequency of hospital admissions and emergency department (ED) visits in the past 12 months. From: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study☆ J Crohns Colitis. 2014;8(7):598-606. doi:10.1016/j.crohns.2013.11.017 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation

4 A) Patient-reported percentage of impairment in work productivity and daily activities because of UC (N = 175). B). Patient-reported percentage of impairment in work productivity and daily activities because of UC by pMayo category. pMayo, Partial Mayo Score; UC, ulcerative colitis. From: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study☆ J Crohns Colitis. 2014;8(7):598-606. doi:10.1016/j.crohns.2013.11.017 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation